Anti-Mullerian Hormone as a New Marker for Diagnosis of Polycystic Ovary Syndrome

    October 2019 in “ The Egyptian Journal of Hospital Medicine ”
    Abdel Monieum Mohamed Zakaria, Ahmed Osama, Ahmed Kamal Mohamed Abo Sheashea
    TLDR AMH is a reliable marker for diagnosing PCOS.
    The study assessed the accuracy of Anti-Mullerian Hormone (AMH) as a diagnostic marker for Polycystic Ovary Syndrome (PCOS) in a retrospective study involving 130 women, with 100 diagnosed with PCOS and 30 as controls. Results indicated that AMH levels were significantly higher in PCOS patients compared to controls, with a sensitivity of 98%, specificity of 80%, and total accuracy of 93% at a cutoff point of 0.911. The study concluded that AMH is a reliable, objective, and quantitative marker for diagnosing PCOS, unaffected by menstrual cycle timing or oral contraceptive use, suggesting the need for further studies to validate its diagnostic role.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community I wish we didn’t have to live with this….

       61 upvotes 6 years ago
      The struggles of hair loss at a young age and available treatments, such as medication (Finasteride, Minoxidil, Dutasteride, Derma Rolling) and potential options for hair systems or cloning in Japan. People discussed their own experiences with trying to cope with the emotional aspects of this condition.

      community 9 months on Finasteride 1,25mg + HRT

      in Transgender  17 upvotes 1 year ago
      The conversation is about the results of using hormone replacement therapy (HRT) with estrogen and finasteride for hair loss, and switching from finasteride to bicalutamide as an anti-androgen treatment. The user shared before and after photos to discuss the effectiveness of these treatments.

    Related Research

    3 / 3 results